2 months ago
ARCT
AnalystsWhitney IjemWhitney Ijem's Stock Forecasts
AnalystsWhitney Ijem
Sectors:
Industries:
Analyst Ranking
Top 13%
#554 out of 4575 analysts
Average Return
+23.76%
Win Rate
47%18 out of 38
Risk vs Reward
Poor
Good
Whitney Ijem's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcturus Therapeutics Holdings IncARCT | +606.98% | $12.03 | $85.05 | 2020-02-06 - 2021-02-05 | Strong Buy |
Taysha Gene Therapies IncTSHA | +292.22% | $0.67 | $2.62 | 2023-07-05 - 2024-05-06 | Strong Buy |
Sigilon Therapeutics IncSGTX | +214.79% | $7.14 | $22.47 | 2023-01-17 - 2023-08-10 | Strong Buy |
Regulus Therapeutics IncRGLS | +88.37% | $1.29 | $2.43 | 2023-09-20 - 2024-05-06 | Strong Buy |
Rhythm Pharmaceuticals IncRYTM | +79.58% | $24.34 | $43.71 | 2023-03-01 - 2024-03-01 | Strong Buy |
Whitney Ijem Analyst Color
Get additional color on Whitney Ijem's coverage of popular stocks
8 months ago
RGLS
10 months ago
SGTX
Whitney Ijem's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical IncRARE | 3 | Strong Buy | $109.00 | +153.43% | Maintains | a day ago |
Biomarin Pharmaceutical IncBMRN | 5 | Hold | $89.00 | +8.40% | Maintains | 12 days ago |
Vertex Pharmaceuticals IncVRTX | 5 | Strong Sell | $371.00 | -7.83% | Maintains | a month ago |
Taysha Gene Therapies IncTSHA | 6 | Strong Buy | $7.00 | +167.18% | Reiterates | 2 months ago |
Tenaya Therapeutics IncTNYA | 3 | Strong Buy | $18.00 | +296.48% | Maintains | 2 months ago |
Regulus Therapeutics IncRGLS | 3 | Strong Buy | $11.00 | +352.67% | Maintains | 2 months ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Strong Buy | $87.00 | +218.45% | Maintains | 2 months ago |
Passage Bio IncPASG | 2 | Strong Buy | $14.00 | +892.91% | Reiterates | 2 months ago |
Intellia Therapeutics IncNTLA | 3 | Strong Buy | $73.00 | +207.76% | Maintains | 2 months ago |
Rocket Pharmaceuticals IncRCKT | 2 | Strong Buy | $47.00 | +102.59% | Maintains | 9 months ago |
Sigilon Therapeutics IncSGTX | 2 | Strong Buy | $30.00 | +33.51% | Maintains | 10 months ago |
Verve Therapeutics IncVERV | 2 | Strong Buy | $29.00 | +352.42% | Reiterates | a year ago |
Rhythm Pharmaceuticals IncRYTM | 1 | Strong Buy | $56.00 | N/A | Maintains | a year ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $291.00 | N/A | Maintains | a year ago |
Generation Bio CoGBIO | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | a year ago |
Neubase Therapeutics IncNBSE | 1 | Strong Buy | $260.00 | N/A | Initiates Coverage On | 4 years ago |
Karyopharm Therapeutics IncKPTI | 3 | Hold | $7.00 | N/A | Downgrades | 5 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.